Ansgar Hebborn

650 total citations
12 papers, 481 citations indexed

About

Ansgar Hebborn is a scholar working on Economics and Econometrics, Physiology and General Health Professions. According to data from OpenAlex, Ansgar Hebborn has authored 12 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 5 papers in Physiology and 2 papers in General Health Professions. Recurrent topics in Ansgar Hebborn's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Biomedical Ethics and Regulation (5 papers) and Pharmaceutical Economics and Policy (3 papers). Ansgar Hebborn is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Biomedical Ethics and Regulation (5 papers) and Pharmaceutical Economics and Policy (3 papers). Ansgar Hebborn collaborates with scholars based in Switzerland, Italy and France. Ansgar Hebborn's co-authors include Joyce A. Cramer, Roy D. Altman, Mayur M. Amonkar, Gaby Sroczynski, Ruth Schwarzer, Uwe Siebert, Petra Schnell‐Inderst, Bernhard Bornschein, Kim Saverno and Diana Brixner and has published in prestigious journals such as International Journal of Cardiology, Value in Health and Current Medical Research and Opinion.

In The Last Decade

Ansgar Hebborn

12 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ansgar Hebborn Switzerland	8	250	233	129	66	49	12	481
Marilyn Arnold United States	8	164 0.7×	52 0.2×	27 0.2×	96 1.5×	26 0.5×	20	325
Julian Nam Canada	12	124 0.5×	51 0.2×	47 0.4×	138 2.1×	38 0.8×	24	430
Chun‐Lan Chang United States	11	97 0.4×	53 0.2×	49 0.4×	53 0.8×	6 0.1×	27	400
Carlo Tringale United States	4	307 1.2×	182 0.8×	43 0.3×	185 2.8×	34 0.7×	5	498
Ruili Luo United States	9	17 0.1×	87 0.4×	66 0.5×	79 1.2×	34 0.7×	14	368
Akeem Yusuf United States	10	99 0.4×	57 0.2×	19 0.1×	87 1.3×	17 0.3×	34	362
Sarah Leyland United Kingdom	7	279 1.1×	77 0.3×	21 0.2×	139 2.1×	32 0.7×	11	467
Kimberly Ruiz United States	6	51 0.2×	37 0.2×	27 0.2×	29 0.4×	12 0.2×	15	319
Philip Madvig United States	9	97 0.4×	66 0.3×	92 0.7×	11 0.2×	129 2.6×	10	403
Sally R. Hinchliffe United Kingdom	11	25 0.1×	134 0.6×	66 0.5×	117 1.8×	27 0.6×	13	417

Countries citing papers authored by Ansgar Hebborn

Since Specialization

Citations

This map shows the geographic impact of Ansgar Hebborn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ansgar Hebborn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ansgar Hebborn more than expected).

Fields of papers citing papers by Ansgar Hebborn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ansgar Hebborn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ansgar Hebborn. The network helps show where Ansgar Hebborn may publish in the future.

Co-authorship network of co-authors of Ansgar Hebborn

This figure shows the co-authorship network connecting the top 25 collaborators of Ansgar Hebborn. A scholar is included among the top collaborators of Ansgar Hebborn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ansgar Hebborn. Ansgar Hebborn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Solà-Morales, Oriol, Mondher Toumi, Heiner C. Bucher, et al.. (2022). Shaping a research agenda to ensure a successful European health technology assessment: insights generated during the inaugural convention of the European Access Academy. Health Economics Review. 12(1). 54–54. 7 indexed citations

Solà-Morales, Oriol, et al.. (2022). How can a joint European health technology assessment provide an ‘additional benefit’ over the current standard of national assessments?. Health Economics Review. 12(1). 30–30. 17 indexed citations

Tafuri, Giovanni, Carlo Favaretti, Ansgar Hebborn, et al.. (2020). The fourth edition of the European Network for Health Technology Assessment Forum: highlights and outcomes. International Journal of Technology Assessment in Health Care. 36(3). 191–196. 1 indexed citations

Giuliani, Giovanni, et al.. (2018). Leveraging EUnetHTA’s conceptual framework to compare HTA decision drivers in France, Italy, and Germany from a manufacturer’s point of view. Health Economics Review. 8(1). 24–24. 8 indexed citations

Gyldmark, Marlene, et al.. (2018). IS THE EUNETHTA HTA CORE MODEL® FIT FOR PURPOSE? EVALUATION FROM AN INDUSTRY PERSPECTIVE. International Journal of Technology Assessment in Health Care. 34(5). 458–463. 13 indexed citations

Schwarzer, Ruth, Ursula Rochau, Kim Saverno, et al.. (2015). Systematic overview of cost–effectiveness thresholds in ten countries across four continents. Journal of Comparative Effectiveness Research. 4(5). 485–504. 102 indexed citations

Schnell‐Inderst, Petra, Agnes Luzak, Stefanie Bühn, et al.. (2015). Results of an International Expert Task Force on a Health Technology Assessment Framework for Personalized Medicine in Cancer. Research Explorer (The University of Manchester). 1 indexed citations

Hebborn, Ansgar, et al.. (2014). A Comparison of International Health Technology Assessment Systems – Does The Perfect System Exist?. Value in Health. 17(7). A441–A441. 3 indexed citations

Stewart, Simon, John J.V. McMurray, Ansgar Hebborn, Andrew J.S. Coats, & Milton Packer. (2005). Carvedilol reduces the costs of medical care in severe heart failure: An economic analysis of the COPERNICUS study applied to the United Kingdom. International Journal of Cardiology. 100(1). 143–149. 10 indexed citations

10.

Cramer, Joyce A., Mayur M. Amonkar, Ansgar Hebborn, & Roy D. Altman. (2005). Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Current Medical Research and Opinion. 21(9). 1453–1460. 311 indexed citations

11.

Simon, J, et al.. (2005). Bisphosphonate dosing preferences in women with postmenopausal osteoporosis: a study.. 30(7). 7 indexed citations

12.

Hebborn, Ansgar, et al.. (1996). FOCUS: Not‐for‐profit Health Services and the German Health Care System. Business Ethics A European Review. 5(4). 212–218. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact